Nardon, Chiara
Nardon, Chiara
DIPARTIMENTO DI BIOTECNOLOGIE
20S proteasome inhibition by gold(III)-based antitumor agents: from in vitro and in vivo studies to X-ray crystallography
2015-01-01 Nardon, C.; Cendron, L.; Dou, Q. P.; Beck, P.; Groll, M.; Zanotti, G.; Fregona, D.
A new strategy in chemotherapy: preliminary studies on Cu(II) complexes aimed at exploiting the enhanced copper uptake in malignancies
2012-01-01 Adami, A.; Dalla Via, L.; Imberti, C.; Nardon, C.; Marchiò, L.; Di Noto, V.; Fregona, D.
An excellence in medicinal inorganic chemistry: a portrait of the gold(I/III) complexes patented for therapeutic purposes from 2010 to 2015
2015-01-01 Pettenuzzo, N.; Brustolin, L.; Nardon, C.; Fregona, D.
Anticancer Gold(III) Peptidomimetics: From Synthesis to in vitro and ex vivo Biological Evaluations
2018-01-01 Boscutti, Giulia; Nardon, Chiara; Marchiò, Luciano; Crisma, Marco; Biondi, Barbara; Dalzoppo, Daniele; Dalla Via, Lisa; Formaggio, Fernando; Casini, Angela; Fregona, Dolores
Au(III)-Proline derivatives exhibiting selective antiproliferative activity against HepG2/SB3 apoptosis-resistant cancer cells
2019-01-01 Brustolin, L.; Pettenuzzo, N.; Nardon, C.; Quarta, S.; Marchio, L.; Biondi, B.; Pontisso, P.; Fregona, D.
Beyond Platinums: Gold Complexes as Anticancer Agents
2014-01-01 Nardon, Chiara; Boscutti, Giulia; Dolores, Fregona
Biological studies on Au(III) peptidomimetics about to enter Phase I clinical trials
2012-01-01 Nardon, C.; Ronconi, L.; Boscutti, G.; Paolini, M.; Formaggio, F.; Fregona, D.
CCK8 peptide-labeled Pluronic® F127 micelles as a targeted vehicle of gold-based anticancer chemotherapeutics
2015-01-01 Nardon, Chiara; Boscutti, Giulia; DALLA VIA, Lisa; Paola, Ringhieri; DI NOTO, Vito; Giancarlo, Morelli; Antonella, Accardo; Fregona, Dolores
CCK8 receptor-mediated cancer treatment strategies in target therapy
2013-01-01 Nardon, Chiara; A., Accardo; Boscutti, Giulia; DI NOTO, Vito; DALLA VIA, Lisa; Fregona, Dolores; G., Morelli
Cell and cell-free mechanistic studies on two gold(III) complexes with proved antitumor properties
2017-01-01 Nardon, Chiara; Boscutti, Giulia; Gabbiani, Chiara; Massai, Lara; Pettenuzzo, Nicolo'; Fassina, Ambrogio; Messori, Luigi; Fregona, Dolores
Cellular and Computational Studies of Proteasome Inhibition and Apoptosis Induction in Human Cancer Cells by Amino Acid Schiff Base-Copper Complexes
2013-01-01 J., Zuo; C., Bi; Y., Fan; D., Buac; Nardon, Chiara; K. G., Daniel; Q. P., Dou
Circularly Polarized Luminescence from New Heteroleptic Eu(III) and Tb(III) Complexes
2023-01-01 Ruggieri, Silvia; Mizzoni, Silvia; Nardon, Chiara; Cavalli, Enrico; Sissa, Cristina; Anselmi, Michele; Cozzi, Pier Giorgio; Gualandi, Andrea; Sanadar, Martina; Melchior, Andrea; Zinna, Francesco; Willis, Oliver G.; Di Bari, Lorenzo; Piccinelli, Fabio
Composti di coordinazione, sintesi, nanoformulazione ed uso degli stessi come antinfiammatori” n° domanda:102016000122377, brevetto per invenzione industriale (antiflogistic),
2017-01-01 Fregona, D.; Nardon, C.
COMPOSTI DI COORDINAZIONE, SINTESI, NANOFORMULAZIONE ED USO DEGLI STESSI IN ONCOLOGIA (Au, Cu)
2016-01-01 Fregona, Dolores; Nardon, Chiara; Brustolin, Leonardo; Pettenuzzo, Nicolò
COMPOSTI DI COORDINAZIONE, SINTESI, NANOFORMULAZIONE ED USO DEGLI STESSI IN ONCOLOGIA (Ru, Ga)
2016-01-01 Fregona, Dolores; Nardon, Chiara; Brustolin, Leonardo; Pettenuzzo, Nicolò
Copper(II)- and Ruthenium(III)-based complexes with promising anticancer activity
2013-01-01 Nardon, C.; Adami, A.; Boscutti, G.; Marchiò, L.; Dalla Via, L.; Fregona, D.
CuII and AuIII Complexes with Glycoconjugated Dithiocarbamato Ligands for Potential Applications in Targeted Chemotherapy
2019-01-01 Pettenuzzo, N; Brustolin, L; Coltri, Elisa; Gambalunga, A; Chiara, F; Trevisan, A; Biondi, B; Nardon, C; Fregona, D.
Cutting-edge anticancer agents: gold-based peptidomimetics targeting peptide transporters
2013-01-01 Nardon, Chiara; Q. P., Dou; Fregona, Dolores
Cutting-Edge Nanosystems for Biomedical Applications
2015-01-01 Nardon, Chiara; Fregona, Dolores
Design and development of new metal-based biosensors for the early detection of cancer antigens in oncology
2009-01-01 Nardon, C.; Ronconi, L.; Sitran, S.; Favaro, M.; Fregona, D.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 20S proteasome inhibition by gold(III)-based antitumor agents: from in vitro and in vivo studies to X-ray crystallography | 1-gen-2015 | Nardon, C.; Cendron, L.; Dou, Q. P.; Beck, P.; Groll, M.; Zanotti, G.; Fregona, D. | |
| A new strategy in chemotherapy: preliminary studies on Cu(II) complexes aimed at exploiting the enhanced copper uptake in malignancies | 1-gen-2012 | Adami, A.; Dalla Via, L.; Imberti, C.; Nardon, C.; Marchiò, L.; Di Noto, V.; Fregona, D. | |
| An excellence in medicinal inorganic chemistry: a portrait of the gold(I/III) complexes patented for therapeutic purposes from 2010 to 2015 | 1-gen-2015 | Pettenuzzo, N.; Brustolin, L.; Nardon, C.; Fregona, D. | |
| Anticancer Gold(III) Peptidomimetics: From Synthesis to in vitro and ex vivo Biological Evaluations | 1-gen-2018 | Boscutti, Giulia; Nardon, Chiara; Marchiò, Luciano; Crisma, Marco; Biondi, Barbara; Dalzoppo, Daniele; Dalla Via, Lisa; Formaggio, Fernando; Casini, Angela; Fregona, Dolores | |
| Au(III)-Proline derivatives exhibiting selective antiproliferative activity against HepG2/SB3 apoptosis-resistant cancer cells | 1-gen-2019 | Brustolin, L.; Pettenuzzo, N.; Nardon, C.; Quarta, S.; Marchio, L.; Biondi, B.; Pontisso, P.; Fregona, D. | |
| Beyond Platinums: Gold Complexes as Anticancer Agents | 1-gen-2014 | Nardon, Chiara; Boscutti, Giulia; Dolores, Fregona | |
| Biological studies on Au(III) peptidomimetics about to enter Phase I clinical trials | 1-gen-2012 | Nardon, C.; Ronconi, L.; Boscutti, G.; Paolini, M.; Formaggio, F.; Fregona, D. | |
| CCK8 peptide-labeled Pluronic® F127 micelles as a targeted vehicle of gold-based anticancer chemotherapeutics | 1-gen-2015 | Nardon, Chiara; Boscutti, Giulia; DALLA VIA, Lisa; Paola, Ringhieri; DI NOTO, Vito; Giancarlo, Morelli; Antonella, Accardo; Fregona, Dolores | |
| CCK8 receptor-mediated cancer treatment strategies in target therapy | 1-gen-2013 | Nardon, Chiara; A., Accardo; Boscutti, Giulia; DI NOTO, Vito; DALLA VIA, Lisa; Fregona, Dolores; G., Morelli | |
| Cell and cell-free mechanistic studies on two gold(III) complexes with proved antitumor properties | 1-gen-2017 | Nardon, Chiara; Boscutti, Giulia; Gabbiani, Chiara; Massai, Lara; Pettenuzzo, Nicolo'; Fassina, Ambrogio; Messori, Luigi; Fregona, Dolores | |
| Cellular and Computational Studies of Proteasome Inhibition and Apoptosis Induction in Human Cancer Cells by Amino Acid Schiff Base-Copper Complexes | 1-gen-2013 | J., Zuo; C., Bi; Y., Fan; D., Buac; Nardon, Chiara; K. G., Daniel; Q. P., Dou | |
| Circularly Polarized Luminescence from New Heteroleptic Eu(III) and Tb(III) Complexes | 1-gen-2023 | Ruggieri, Silvia; Mizzoni, Silvia; Nardon, Chiara; Cavalli, Enrico; Sissa, Cristina; Anselmi, Michele; Cozzi, Pier Giorgio; Gualandi, Andrea; Sanadar, Martina; Melchior, Andrea; Zinna, Francesco; Willis, Oliver G.; Di Bari, Lorenzo; Piccinelli, Fabio | |
| Composti di coordinazione, sintesi, nanoformulazione ed uso degli stessi come antinfiammatori” n° domanda:102016000122377, brevetto per invenzione industriale (antiflogistic), | 1-gen-2017 | Fregona, D.; Nardon, C. | |
| COMPOSTI DI COORDINAZIONE, SINTESI, NANOFORMULAZIONE ED USO DEGLI STESSI IN ONCOLOGIA (Au, Cu) | 1-gen-2016 | Fregona, Dolores; Nardon, Chiara; Brustolin, Leonardo; Pettenuzzo, Nicolò | |
| COMPOSTI DI COORDINAZIONE, SINTESI, NANOFORMULAZIONE ED USO DEGLI STESSI IN ONCOLOGIA (Ru, Ga) | 1-gen-2016 | Fregona, Dolores; Nardon, Chiara; Brustolin, Leonardo; Pettenuzzo, Nicolò | |
| Copper(II)- and Ruthenium(III)-based complexes with promising anticancer activity | 1-gen-2013 | Nardon, C.; Adami, A.; Boscutti, G.; Marchiò, L.; Dalla Via, L.; Fregona, D. | |
| CuII and AuIII Complexes with Glycoconjugated Dithiocarbamato Ligands for Potential Applications in Targeted Chemotherapy | 1-gen-2019 | Pettenuzzo, N; Brustolin, L; Coltri, Elisa; Gambalunga, A; Chiara, F; Trevisan, A; Biondi, B; Nardon, C; Fregona, D. | |
| Cutting-edge anticancer agents: gold-based peptidomimetics targeting peptide transporters | 1-gen-2013 | Nardon, Chiara; Q. P., Dou; Fregona, Dolores | |
| Cutting-Edge Nanosystems for Biomedical Applications | 1-gen-2015 | Nardon, Chiara; Fregona, Dolores | |
| Design and development of new metal-based biosensors for the early detection of cancer antigens in oncology | 1-gen-2009 | Nardon, C.; Ronconi, L.; Sitran, S.; Favaro, M.; Fregona, D. |